Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonas Dudda

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|June 9, 2026
Even mild elevations of C-reactive protein levels predict long-term prognosis in heart failure with mildly reduced ejection fractionJonas Dudda, Michael Behnes, Michelle Goertz, et al.
International Journal of Cardiology|December 4, 2024
Potassium levels and short-term outcomes in heart failure with mildly reduced ejection fractionMarielen Reinhardt, Michael Behnes, Kathrin Weidner, et al.
International Journal of Molecular Sciences|April 28, 2023
Does Albumin Predict the Risk of Mortality in Patients with Cardiogenic Shock?Tobias Schupp, Michael Behnes, Jonas Rusnak, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|April 24, 2023
Prognosis of cardiogenic shock with and without acute myocardial infarction: results from a prospective, monocentric registryTobias Schupp, Jonas Rusnak, Sascha Egner-Walter, et al.
Irish Journal of Medical Science|May 19, 2023
C-reactive protein and procalcitonin during course of sepsis and septic shockTobias Schupp, Kathrin Weidner, Jonas Rusnak, et al.
European Journal of Internal Medicine|September 17, 2025
Prognostic impact of left ventricular dilatation in heart failure with mildly reduced ejection fractionHenning Johann Steffen, Michael Behnes, Jonas Dudda, et al.
European Journal of Preventive Cardiology|June 3, 2024
Prognosis and treatment strategies for atrial fibrillation in heart failure with mildly reduced ejection fractionTobias Schupp, Alexander Schmitt, Marielen Reinhardt, et al.
Chest|August 14, 2023
Effect of Admission and Onset Time on the Prognosis of Patients With Cardiogenic ShockMichael Behnes, Jonas Rusnak, Sascha Egner-Walter, et al.
Coronary Artery Disease|April 14, 2026
Long-term prognostic impact of atrial fibrillation subtypes in unselected patients undergoing coronary angiographyHenning Johann Steffen, Tobias Schupp, Mohammad Abumayyaleh, et al.
Endocrine|July 13, 2026
Thyroid function and outcomes in heart failure with mildly reduced ejection fraction: insights from a large, retrospective registryMohammad Abumayyaleh, Ibrahim Akin, Michelle Goertz, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|June 9, 2026
Even mild elevations of C-reactive protein levels predict long-term prognosis in heart failure with mildly reduced ejection fractionJonas Dudda, Michael Behnes, Michelle Goertz, et al.
International Journal of Cardiology|December 4, 2024
Potassium levels and short-term outcomes in heart failure with mildly reduced ejection fractionMarielen Reinhardt, Michael Behnes, Kathrin Weidner, et al.
International Journal of Molecular Sciences|April 28, 2023
Does Albumin Predict the Risk of Mortality in Patients with Cardiogenic Shock?Tobias Schupp, Michael Behnes, Jonas Rusnak, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|April 24, 2023
Prognosis of cardiogenic shock with and without acute myocardial infarction: results from a prospective, monocentric registryTobias Schupp, Jonas Rusnak, Sascha Egner-Walter, et al.
Irish Journal of Medical Science|May 19, 2023
C-reactive protein and procalcitonin during course of sepsis and septic shockTobias Schupp, Kathrin Weidner, Jonas Rusnak, et al.
European Journal of Internal Medicine|September 17, 2025
Prognostic impact of left ventricular dilatation in heart failure with mildly reduced ejection fractionHenning Johann Steffen, Michael Behnes, Jonas Dudda, et al.
European Journal of Preventive Cardiology|June 3, 2024
Prognosis and treatment strategies for atrial fibrillation in heart failure with mildly reduced ejection fractionTobias Schupp, Alexander Schmitt, Marielen Reinhardt, et al.
Chest|August 14, 2023
Effect of Admission and Onset Time on the Prognosis of Patients With Cardiogenic ShockMichael Behnes, Jonas Rusnak, Sascha Egner-Walter, et al.
Coronary Artery Disease|April 14, 2026
Long-term prognostic impact of atrial fibrillation subtypes in unselected patients undergoing coronary angiographyHenning Johann Steffen, Tobias Schupp, Mohammad Abumayyaleh, et al.
Endocrine|July 13, 2026
Thyroid function and outcomes in heart failure with mildly reduced ejection fraction: insights from a large, retrospective registryMohammad Abumayyaleh, Ibrahim Akin, Michelle Goertz, et al.
Pageof 4